Cohort profile: the Maharashtra Anaemia Study 3 (MAS 3)—a maternal-child cohort study up to age 18 years in India
MAS 3 will be used to address a number of research objectives, including (1) Trends of haemoglobin and anaemia-related micronutrients from age 6 to 18 years, (2) Micronutrient causes of anaemia during childhood, (3) Prevalence and risk factors for maternal anaemia and childhood anaemia, (4) Impact of maternal anaemia on immediate birth outcomes and (5) Intergenerational risk factors associated with anaemia.
Authors
- Andrew Fogarty (ORCID: https://orcid.org/0000-0001-9426-977X)
- Kourosh R. Ahmadi (ORCID: https://orcid.org/0000-0002-4426-4601)
- Chittaranjan S. Yajnik (ORCID: https://orcid.org/0000-0002-2911-2378)
- Anand Ahankari (ORCID: https://orcid.org/0000-0001-8695-8938)
- Nophar Geifman (ORCID: https://orcid.org/0000-0003-2956-6676)
- Melissa Benavente (ORCID: https://orcid.org/0000-0002-1908-2742)
- Laila J. Tata (ORCID: https://orcid.org/0000-0002-6404-8658)
- Sarah C. Bath (ORCID: https://orcid.org/0000-0001-5391-9932)
- Charles R. Marshall (ORCID: https://orcid.org/0000-0002-8227-2354)
- Sumantra Ray (ORCID: https://orcid.org/0000-0003-3295-168X)
Institutions
- Manchester Metropolitan University (GB)
- University of Ulster (GB)
- University of Nottingham (GB)
- Queen Mary University of London (GB)
- University of Surrey (GB)
- King Edward Memorial Hospital Research Centre (IN)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjopen-2025-104184
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- University of Surrey